Question 1

What is STERIS's P/S ratio?

Accepted Answer

STERIS (STE) P/S ratio is 3.5× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for STERIS?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For STERIS specifically, the relevant sector benchmark is the current sector median of 3.5×.

Question 5

Is STERIS's P/S ratio high or low?

Accepted Answer

STERIS's P/S ratio of 3.5× is below its own 5-year average of 4.4× and above the sector median of 3.5×. That places the current reading at the 2th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is STERIS's historical P/S ratio range?

Accepted Answer

In the available daily series, STERIS (STE) P/S ratio has ranged from a low of 1.0× in 2009 to a high of 6.4× in 2021. The 5-year average is 4.4× and the 5-year median is 4.3×.

Question 7

What was STERIS's P/S ratio in 2026?

Accepted Answer

STERIS (STE) P/S ratio at the end of 2026 was 3.7×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does STERIS's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2026	$21.67B	$5.94B	3.7×	-0.4×	Mar 31, 2026
2025	$22.27B	$5.46B	4.1×	-0.4×	Mar 31, 2025
2024	$21.85B	$4.84B	4.5×	+0.7×	Mar 31, 2024
2023	$18.95B	$4.96B	3.8×	-1.5×	Mar 31, 2023
2022	$24.20B	$4.59B	5.3×	+0.0×	Mar 31, 2022
2021	$16.26B	$3.11B	5.2×	+1.3×	Mar 31, 2021
2020	$11.88B	$3.03B	3.9×	+0.0×	Mar 31, 2020
2019	$10.77B	$2.78B	3.9×	+0.8×	Mar 31, 2019
2018	$7.92B	$2.62B	3.0×	+0.8×	Mar 31, 2018
2017	$5.90B	$2.61B	2.3×	-0.5×	Mar 31, 2017
2016	$6.10B	$2.24B	2.7×	+0.5×	Mar 31, 2016
2015	$4.19B	$1.85B	2.3×	+0.5×	Mar 31, 2015
2014	$2.81B	$1.62B	1.7×	+0.1×	Mar 31, 2014
2013	$2.41B	$1.50B	1.6×	+0.3×	Mar 31, 2013
2012	$1.82B	$1.41B	1.3×	-0.4×	Mar 31, 2012
2011	$2.05B	$1.21B	1.7×	+0.1×	Mar 31, 2011
2010	$1.98B	$1.26B	1.6×	+0.5×	Mar 31, 2010
2009	$1.36B	$1.30B	1.0×	-0.3×	Mar 31, 2009
2008	$1.65B	$1.27B	1.3×	-0.1×	Mar 31, 2008
2007	$1.71B	$1.20B	1.4×	+0.0×	Mar 31, 2007
2006	$1.65B	$1.16B	1.4×	-0.2×	Mar 31, 2006
2005	$1.76B	$1.11B	1.6×	-0.0×	Mar 31, 2005
2004	$1.77B	$1.09B	1.6×	-0.2×	Mar 31, 2004
2003	$1.81B	$972.09M	1.9×	+0.2×	Mar 31, 2003
2002	$1.46B	$866.70M	1.7×	—	Mar 31, 2002


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for STERIS (STE)

P/S Ratio daily chart for STERIS (STE)

Historical P/S Ratio for STERIS (STE) from 2002 to 2026

About P/S Ratio at STERIS (STE)

STERIS P/S Ratio by Year

STERIS P/S Ratio 2026: 3.7×

STERIS P/S Ratio 2025: 4.1×

STERIS P/S Ratio 2024: 4.5×

STERIS P/S Ratio 2023: 3.8×

STERIS P/S Ratio 2022: 5.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

STERIS (STE) Key Financials

P/S Ratio daily chart for STERIS (STE)

Historical P/S Ratio for STERIS (STE) from 2002 to 2026

About P/S Ratio at STERIS (STE)

STERIS P/S Ratio by Year

STERIS P/S Ratio 2026: 3.7×

STERIS P/S Ratio 2025: 4.1×

STERIS P/S Ratio 2024: 4.5×

STERIS P/S Ratio 2023: 3.8×

STERIS P/S Ratio 2022: 5.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is STERIS's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for STERIS?

+Is STERIS's P/S ratio high or low?

+What is STERIS's historical P/S ratio range?

+What was STERIS's P/S ratio in 2026?

+Why does STERIS's P/S ratio change over time?

STERIS (STE) Key Financials